PST

ProShares Trust UltraShort Lehman 7-10 Year Treasury

$22.16
+0.00%
Market closed. Last update: 11:44 PM ET

📎 Investment Objective

The ProShares Trust UltraShort Lehman 7-10 Year Treasury (PST) seeks to provide investment results that correspond to the inverse (-2x) of the daily performance of the Barclays Capital 7-10 Year U.S. Treasury Index.

Overview

ETF tracking ProShares Trust UltraShort Lehman 7-10 Year Treasury

Category Treasury
Issuer ProShares
Inception Date 2008-11-12
Market Cap $12.2M
Average Volume N/A
Dividend Yield 3.66%
52-Week Range $21.59 - $24.99
VWAP $22.09

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The ProShares Trust UltraShort Lehman 7-10 Year Treasury (PST) seeks to provide investment results that correspond to the inverse (-2x) of the daily performance of the Barclays Capital 7-10 Year U.S. Treasury Index.

🎯 Investment Strategy

The fund uses derivatives, such as futures contracts and swap agreements, to provide the desired inverse exposure to the target index. This strategy aims to generate gains when the underlying Treasury securities decline in value.

✨ Key Features

  • Provides inverse (-2x) exposure to the Barclays Capital 7-10 Year U.S. Treasury Index
  • Utilizes derivatives to achieve its investment objective
  • Designed for short-term trading and not intended for long-term buy-and-hold investors
  • Has a very low expense ratio of 0.00%

⚠️ Primary Risks

  • Inverse and leveraged exposure can magnify losses during periods of rising Treasury prices
  • Derivative instruments used by the fund may not perfectly track the target index
  • Potential for significant volatility and risk of loss, especially over longer holding periods
  • Limited performance history and low assets under management

👤 Best For

This ETF is best suited for experienced, sophisticated investors who have a high risk tolerance and are looking to make short-term, speculative bets against the performance of intermediate-term U.S. Treasury securities. It is not recommended for long-term, buy-and-hold investors.